What methylfolate dosage is recommended for a patient with an MTHFR polymorphism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Methylfolate Dosing for MTHFR Polymorphism

For patients with MTHFR polymorphisms, prescribe L-methylfolate 5-15 mg daily, regardless of specific genotype (C677T or A1298C), as this bypasses the enzymatic block and avoids the risks of high-dose synthetic folic acid. 1

FDA-Approved Dosing

The FDA-labeled indication for L-methylfolate calcium tablets specifies use "regardless of MTHFR C677T polymorphism genotype" 1. Available formulations are:

  • 7.5 mg tablets
  • 15 mg tablets

These doses are indicated for individuals with suboptimal L-methylfolate levels who have major depressive disorder or schizophrenia, and importantly, the labeling emphasizes use regardless of specific MTHFR genotype 1.

Clinical Evidence Supporting Specific Doses

Standard Dosing: 5 mg Daily

The most robust clinical evidence supports 5 mg daily of methylfolate for MTHFR carriers. Research in reproductive medicine demonstrates that 5 mg methylfolate daily (combined with vitamin B6 50 mg/day and B12 1 mg/week) successfully reduced homocysteine from 19.4±5.3 μmol/L to 6.9±2.2 μmol/L in patients with MTHFR mutations and recurrent pregnancy loss 2. This regimen resulted in successful pregnancies across all MTHFR mutation types (C677T homozygous, A1298C homozygous, and compound heterozygous) 2.

Another fertility study using 600 mcg (0.6 mg) daily for 4 months in MTHFR carriers achieved successful conception in 30 of 33 couples who had previously failed with high-dose synthetic folic acid 3.

Lower Dose Option: 600 mcg Daily

For less severe presentations or preventive use, 600 mcg daily has demonstrated efficacy in fertility optimization for MTHFR carriers, particularly when previous high-dose folic acid (5 mg) failed 3.

Higher Dose: 7.5-15 mg Daily

For neuropsychiatric indications or when lower doses prove insufficient, 7.5-15 mg daily is FDA-approved and clinically validated 1. A recent study showed 5 mg daily improved sleep disturbance significantly in MTHFR carriers within 2 weeks, with continued improvement through 8 weeks 4.

Critical Distinction: Methylfolate vs Folic Acid

Never use high-dose synthetic folic acid (5 mg) in MTHFR carriers. The biochemical block in MTHFR enzyme function prevents proper conversion of folic acid to the active 5-methyltetrahydrofolate form 3. High-dose folic acid leads to unmetabolized folic acid (UMFA) syndrome, which is associated with immune dysfunction and potentially increased cancer risk 3.

The ESPEN guideline clarifies that synthetic folic acid requires conversion to 5-methyltetrahydrofolate (5-MTHF) to become biologically active 5. L-methylfolate bypasses this enzymatic step entirely, making it the physiologically appropriate choice for MTHFR carriers 3.

Practical Dosing Algorithm

  1. Start with 5 mg L-methylfolate daily for most MTHFR carriers with clinical manifestations (hyperhomocysteinemia, recurrent pregnancy loss, neuropsychiatric symptoms)

  2. Add cofactors for homocysteine management:

    • Vitamin B6: 50 mg daily
    • Vitamin B12: 1 mg weekly (or equivalent daily dosing)
    • These enhance homocysteine remethylation 2

  3. Target homocysteine <10 μmol/L for optimal cardiovascular protection 6

  4. Consider dose adjustment:

    • Increase to 7.5-15 mg if inadequate response after 4-8 weeks
    • May use 600 mcg for mild cases or prevention

  5. Monitor response at 2,4, and 8 weeks with homocysteine levels and clinical symptoms 4, 2

Common Pitfalls to Avoid

  • Do not assume normal serum B12 rules out deficiency - metabolic B12 deficiency occurs in 10.6% of stroke patients despite normal serum levels 6
  • Do not use dietary folate equivalents (DFE) calculations for MTHFR carriers - they need the active form directly 5
  • Do not continue synthetic folic acid if patient has MTHFR mutations, even at "standard" 400-800 mcg doses 3
  • Do not forget vitamin B12 and B6 supplementation - homocysteine metabolism requires all three B vitamins 6, 2

The evidence consistently demonstrates that methylfolate 5 mg daily represents the optimal balance of efficacy and safety for MTHFR carriers, with flexibility to adjust between 0.6-15 mg based on clinical indication and response.

References

5
Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Related Questions

For a patient with an MTHFR gene mutation, what methylated forms and dosages of vitamin B12 (methylcobalamin) and folate (L‑methylfolate) are recommended?
What supplements should be prescribed for a patient with a pathogenic MTHFR (methylenetetrahydrofolate reductase) gene variant?
What are the implications of being homozygous for the MTHFR (Methylenetetrahydrofolate Reductase) A1298C variant?
What is a suitable 5-MTHF (5-methyltetrahydrofolate) titration schedule for a patient with an MTHFR (methylenetetrahydrofolate reductase) variation?
What is the recommended management approach for individuals with a history of pregnancy loss and suspected or confirmed Methylenetetrahydrofolate Reductase (MTHFR) mutation?
A patient with serum potassium increased from 2.9 mmol/L to 3.3 mmol/L—what oral potassium chloride dose should be prescribed at discharge?
What is the appropriate oseltamivir prophylaxis dose and schedule for a child?
Can a trauma surgeon provide a written surgical protocol for the debridement (toilette) of an exposed distal ulna dislocation?
What is the ACOG‑recommended dose of vaginal terconazole for a pregnant woman at 16 weeks gestation?
What is the likely cause and appropriate management for a throbbing left-sided headache with right-sided neck pain and nausea?
I have a recent white blood cell count of 3.8 K/µL after previous results of 7.4, 7.3, and 7.1 K/µL; what does this low count indicate and what should I do?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.